Toronto Dominion Bank
ASBP

Toronto Dominion Bank’s Aspire Biopharma ASBP Stock Holding History

Toronto Dominion Bank’s Portfolio ASBP Stock Details ASBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.15K Buy
+167
New +$8.89K ﹤0.01% 1969
2025
Q2 		– Sell
-431
Closed -$350K – 2025
2025
Q1 		$350K Buy
+431
New +$2.98M ﹤0.01% 1197

Other funds holding ASBP

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CA
Crewe Advisors Salt Lake City, Utah $1.17B AUM 29.21% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.29% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.55B AUM 28.47% 1-Year Est. Return

Toronto Dominion Bank's ASBP Position: Q1 2026 in Review

Toronto Dominion Bank opened a new position in Aspire Biopharma (ASBP) in Q1 2026: 167 shares worth $5.15K. The stake represents ﹤0.01% of the portfolio and ranks #1969 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in ASBP as recently as Q1 2025.

Toronto Dominion Bank first reported a position in ASBP in Q1 2025 and has held it in 2 quarters since. The position peaked at $350K in Q1 2025. 12 funds tracked by Wall St. Rank hold ASBP as of Q1 2026.

  • Toronto Dominion Bank held 167 shares of Aspire Biopharma worth $5.15K as of Q1 2026.
  • Aspire Biopharma was a new Toronto Dominion Bank position in Q1 2026.
  • Aspire Biopharma made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1969 holding.
  • Toronto Dominion Bank first reported a position in Aspire Biopharma in Q1 2025 and has held it in 2 quarters since.
  • Toronto Dominion Bank's Aspire Biopharma position peaked at $350K in Q1 2025.
  • 12 funds tracked by Wall St. Rank held Aspire Biopharma as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.